IGF2BP2 and esophageal squamous cell carcinoma: Our study found that the TMEM44-AS1-IGF2BP2-GPX4 axis is involved in the pathogenesis and progression of ESCC, providing new diagnostic biomarkers and therapeutic targets for ESCC patients.